PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
- Conditions
- Candidiasis
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 412
- Registration Number
- NCT00163111
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years
- Conditions
- Encephalitis, Tick-borne
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3973
- Registration Number
- NCT00161876
- Locations
- 🇵🇱
Zespol Opieki Zdrowotnej w Debicy, Debica, Poland
🇵🇱PANTAMED sp. z o.o., Olsztyn, Poland
🇵🇱Przedsiebiorstwo Uslug Medycznych "Centrum Medyczne Nowa Huta", Krakow, Poland
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-10-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 136
- Registration Number
- NCT00163098
- Locations
Pfizer Investigational Site
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-09-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00163085
- Locations
- 🇺🇸
Pfizer Investigational Site, Portland, Oregon, United States
The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-09-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT00163059
- Locations
- 🇺🇸
Pfizer Investigational Site, Wichita, Kansas, United States
Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
- Conditions
- Meningococcal Meninigitis, Serogroup C
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 321
- Registration Number
- NCT00161941
- Locations
- 🇩🇪
Löpsinger Strasse 8, Nördlingen, Germany
🇩🇪Solothurner Strasse 2, Heilbronn, Germany
🇩🇪Berneckstrasse 19, Schrammberg, Germany
FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years
- Conditions
- Encephalitis, Tick-borne
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 615
- Registration Number
- NCT00161850
- Locations
- 🇦🇹
Grieskirchner Strasse 17, Wels, Austria
🇩🇪Neuschwanstein Strasse 5, Augsburg, Germany
🇩🇪Marktplatz 33, Bad Saulgau, Germany
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR
- Conditions
- Encephalitis, Tick-borne
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3800
- Registration Number
- NCT00161824
- Locations
- 🇵🇱
Zespol Opieki Zdrowotnej w Debicy, Debica, Poland
🇵🇱Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A, Kielce, Poland
🇵🇱"Atopia" Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego, Krakow, Poland
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
- Conditions
- Tick-borne Encephalitis
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00161798
- Locations
- 🇩🇪
Mohrenstrasse 8, Coburg, Germany
🇩🇪Marktplatz 33, Bad Saulgau, Germany
🇩🇪Berneckstrasse 19, Schrammberg, Germany
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
- Conditions
- Meningitis, Meningococcal
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 330
- Registration Number
- NCT00161928
- Locations
- 🇩🇪
Marktplatz 3, Bad Saulgau, Germany
🇩🇪Neuschwansteinstrasse 5, Augsburg, Germany
🇦🇹Grieskirchner Strasse 17, Wels, Austria